← Association for Accessible Medicines
FDANonrulemakingFDA-2021-D-0391

Oral Drug Products Administered Via Enteral Feeding Tube: In Vitro Testing and Labeling Recommendations; Draft Guidance for Industry; Availability

RIN
—
Last modified
Jan 8, 2026
Comment window
closed 1821d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Aug 5, 2021 and Aug 5, 2021. 0 other organizations filed here. The comment window closed 1821d ago.

What Association for Accessible Medicines filed (1)

Aug 5, 2021· Comment from The Association for Accessible Medicines (AAM)· FDA-2021-D-0391-0007

The Association for Accessible Medicines (AAM) appreciates the opportunity to submit comments on the draft guidance, "Oral Drug Products Administered Via Enteral Feeding Tube: In Vitro Testing and Labeling Recommendations.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →
Oral Drug Products Administered Via Enteral Feeding Tube: In Vitro Testing and Labeling Recommendations; Draft Guidance for Industry; Availability (FDA) — Association for Accessible Medicines | OpenPolis